Association between prothrombin time and bleeding in hospitalized patients receiving rivaroxaban

Keyphrases

• Rivaroxaban 100%
• Hospitalized Patients 100%
• Bleeding 100%
• Prothrombin Time 100%
• Bleeding Events 37%
• Hypoalbuminemia 25%
• Bleeding Risk 25%
• Odds Ratio 12%
• Confidence Interval 12%
• Logistic Regression Model 12%
• Pharmacodynamic Interactions 12%
• Multivariable Logistic Regression 12%
• Retrospective Cohort Study 12%
• Significant Predictors 12%
• Non-steroidal Anti-inflammatory Drugs (NSAIDs) 12%
• Anticoagulation 12%
• Between-group Difference 12%
• Overall Rate 12%
• Single Center 12%
• Multivariable Regression 12%
• Antiplatelet Agents 12%
• Albumin Level 12%
• High Risk of Bleeding 12%
• Regression Modeling 12%
• In-hospital Bleeding 12%
• Time Event 12%
• High Bleeding Risk 12%
• Adult Inpatients 12%
• Coagulation Tests 12%

Nursing and Health Professions

• Bleeding 100%
• Rivaroxaban 100%
• Prothrombin Time 100%
• Thromboembolism 25%
• Hypoalbuminemia 25%
• Odds Ratio 12%
• Confidence Interval 12%
• Logistic Regression Analysis 12%
• Cohort Analysis 12%
• Nonsteroid Antiinflammatory Agent 12%
• Antithrombocytic Agent 12%
• Anticoagulation 12%
• Pharmacodynamics 12%
• Blood Clotting Test 12%
• Albumin Level 12%

Pharmacology, Toxicology and Pharmaceutical Science

• Bleeding 100%
• Rivaroxaban 100%
• Prothrombin 100%
• Thromboembolism 25%
• Hypoalbuminemia 25%
• Pharmacodynamics 12%
• Non-Steroidal Anti-Inflammatory Drug 12%
• Cohort Study 12%
• Antithrombocytic Agent 12%
• Albumin 12%